Nanjing Hicin Pharmaceutical Co., Ltd. (300584.SZ)
CNY 19.45
(0.41%)
CNY 19.45
(0.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 517.83 Million | 526.46 Million | 578.31 Million | 706.29 Million | 924.53 Million | 711.9 Million |
| Cost of Revenue | 96.59 Million | 130.01 Million | 109.01 Million | 171.56 Million | 187.15 Million | 98.04 Million |
| Gross Profit | 421.23 Million | 396.44 Million | 469.3 Million | 534.73 Million | 737.38 Million | 613.85 Million |
| Operating Expenses | 377.26 Million | 351.71 Million | 435.2 Million | 462.96 Million | 614.65 Million | 513.42 Million |
| Selling, General and Administrative Expenses | 283.88 Million | 285.2 Million | 361.73 Million | 397.95 Million | 545.45 Million | 452.05 Million |
| Research and Development Expenses | 61.06 Million | 18.21 Million | 21.69 Million | 31.87 Million | 36.09 Million | 37.53 Million |
| Other Expenses | 1.03 Million | -1.32 Million | 305.28 Million | -1.16 Million | -104.8 Thousand | -547.73 Thousand |
| Cost and Expenses | 478.53 Million | 481.72 Million | 544.21 Million | 634.52 Million | 801.8 Million | 611.46 Million |
| Operating Income | 43.44 Million | 30.1 Million | 331.29 Million | 62.5 Million | 114.26 Million | 96.51 Million |
| Interest Expense | 8.33 Million | 7.25 Million | 7.49 Million | 7 Million | 5.97 Million | 4.05 Million |
| Income Tax Expense | 1.37 Million | -3.34 Million | 45.61 Million | 6.81 Million | 17 Million | 12.74 Million |
| Earnings before Tax | 37.68 Million | 28.77 Million | 330.44 Million | 61.34 Million | 114.16 Million | 95.96 Million |
| Net Income | 36.31 Million | 32.44 Million | 285.87 Million | 55.23 Million | 97.25 Million | 83.22 Million |
| Earnings Per Share Basic | 0.30 | 0.27 | 2.38 | 0.46 | 0.81 | 0.69 |
| Earnings Per Share Diluted | 0.30 | 0.27 | 2.38 | 0.46 | 0.81 | 0.69 |
| Weighted Average Shares Outstanding | 120.01 Million | 120 Million | 120 Million | 120 Million | 120 Million | 120 Million |
| Weighted Average Shares Outstanding (Diluted) | 120.01 Million | 120 Million | 120 Million | 120 Million | 120 Million | 120 Million |
| Gross Margin | 0.81 | 0.75 | 0.81 | 0.76 | 0.80 | 0.86 |
| EBIT Margin | 0.19 | 0.18 | 0.65 | 0.14 | 0.16 | 0.17 |
| Profit Margin | 0.07 | 0.06 | 0.49 | 0.08 | 0.11 | 0.12 |
| EBITDA | 97 Million | 84.17 Million | 375 Million | 100.03 Million | 144.84 Million | 116.84 Million |
| Earnings Before Tax Margin | 0.08 | 0.06 | 0.57 | 0.09 | 0.12 | 0.14 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 123.96 Million | 129.02 Million | 102.14 Million | 506.53 Million | 136.97 Million | 116.4 Million |
| Cost of Revenue | 23.39 Million | 27.42 Million | 18.67 Million | 129.96 Million | 35.99 Million | 23.9 Million |
| Gross Profit | 100.57 Million | 101.59 Million | 83.46 Million | 376.57 Million | 100.98 Million | 92.49 Million |
| Operating Expenses | 93.07 Million | 87.23 Million | 65.35 Million | 333.13 Million | 84.32 Million | 86.4 Million |
| Selling, General and Administrative Expenses | 105.98 Million | 72.32 Million | 56.8 Million | - | 71.37 Million | 98.21 Million |
| Research and Development Expenses | 14.53 Million | 13.64 Million | 5.42 Million | - | 14.44 Million | 8.52 Million |
| Other Expenses | -27.44 Million | -1.27 Million | -3.11 Million | -4.68 Million | 1.5 Million | -245.72 Thousand |
| Cost and Expenses | 116.46 Million | 114.66 Million | 84.03 Million | 463.09 Million | 120.31 Million | 110.31 Million |
| Operating Income | 3.02 Million | 14.36 Million | 18.11 Million | 43.44 Million | 16.66 Million | 2.91 Million |
| Interest Expense | 2.23 Million | 2.51 Million | 2.07 Million | 8.27 Million | 1.65 Million | 2.8 Million |
| Income Tax Expense | -555.51 Thousand | -266.61 Thousand | 2.91 Million | 1.37 Million | 833.83 Thousand | -280.93 Thousand |
| Earnings before Tax | 2.82 Million | 11.11 Million | 16.27 Million | 37.68 Million | 14.72 Million | 2.66 Million |
| Net Income | 3.38 Million | 11.37 Million | 13.35 Million | 36.31 Million | 13.89 Million | 2.94 Million |
| Earnings Per Share Basic | 0.03 | 0.09 | 0.11 | - | 0.12 | 0.02 |
| Earnings Per Share Diluted | 0.03 | 0.09 | 0.11 | - | 0.12 | 0.02 |
| Weighted Average Shares Outstanding | 120 Million | 120 Million | 120 Million | 120 Million | 120 Million | 120 Million |
| Weighted Average Shares Outstanding (Diluted) | 120 Million | 120 Million | 120 Million | 120 Million | 120 Million | 120 Million |
| Gross Margin | 0.81 | 0.79 | 0.82 | 0.74 | 0.74 | 0.79 |
| EBIT Margin | 0.04 | 0.21 | 0.21 | - | 0.22 | 0.06 |
| Profit Margin | 0.03 | 0.09 | 0.13 | 0.07 | 0.10 | 0.03 |
| EBITDA | 5.05 Million | 27.4 Million | 21.25 Million | - | 30.2 Million | 6.85 Million |
| Earnings Before Tax Margin | 0.02 | 0.11 | 0.18 | 0.09 | 0.12 | 0.03 |
ASC
BIAFW
000679
XFLS
SNST
BZ